HIV/AIDS

March 17, 2022

Blood test figures in cancer risk for people with HIV

A Vanderbilt study found that, among adult patients with HIV, those who have lower counts of certain types of blood cells have a markedly higher risk of developing cancer.

By Paul Govern
February 24, 2022

Ahonkhai advances in national challenge to improve HIV care for Black men in Tennessee

A Vanderbilt proposal to implement a novel strategy to use barbers and barbershops to improve HIV care outcomes for Black men with HIV in Middle Tennessee received early-stage funding from a challenge hosted by the U.S. Department of Health and Human Services’ Office of Minority Health.

By Holly Fletcher
July 13, 2021

Establishing HIV care in Tennessee

Vanderbilt researchers find that heterosexually active Black males are the least likely to establish HIV care within one month of diagnosis and suggest that targeted interventions focus on this population.

By Paul Govern
June 18, 2021

The whitewater trip was a disaster. It motivated Renée Garside to become an expert kayaker.

There’s no doubt she loves it, especially when she says things like: “I just love it, love it, love it.”

By Jill Clendening
April 21, 2021

Study finds dramatic gains in life expectancy for people with HIV in Latin America

A research team from Vanderbilt University Medical Center and institutions across Latin America today reports what looks to be far the largest study to date of life expectancy for people living with HIV infection in low-income or middle-income countries.

By Paul Govern
March 18, 2021

HIV, diabetes and immune cells in fat

In HIV-positive individuals with diabetes, immune cells in fat are more proinflammatory and cytotoxic and may represent a therapeutic target for diabetes.

By Leigh MacMillan
March 4, 2021

Clinic helps prepare young HIV patients for adult care

Adolescents and young adults living with HIV in Middle Tennessee are being ushered into adult care through a special transition clinic that focuses on adult skill-building and individualized therapy and discussions.
By Nancy Humphrey
February 18, 2021

VUMC investigator expands HIV research into South Africa

A Vanderbilt University Medical Center investigator is hoping to improve access to HIV testing in South Africa, where more than 7 million people are known to have the virus, by training traditional healers to perform the tests.
By Jake Lowary
February 11, 2021

Clinical Trials Unit lands major grant renewal

Vanderbilt University Medical Center and Washington University School of Medicine in St. Louis have received renewal of a major federal grant to continue their collaboration to test and develop new treatments and vaccines against HIV/AIDS — and now COVID-19.
By Bill Snyder
February 8, 2021

Key factors in HIV-1 replication

HIV-1, the virus that causes AIDS, exploits inositol phosphates in T cells to aid its own assembly and maturation — suggesting that targeting inositol phosphate binding could inhibit HIV-1 replication.
By VUMC News and Communications
December 10, 2020

HIV patients stay away after Nigerian clinic introduces fees

Six years ago, in Nigeria, funding cutbacks for HIV treatment and the consequent introduction of patient fees were associated with sharp declines in new HIV clinic enrollments and patient adherence to antiretroviral therapy (ART).
By Paul Govern
November 2, 2020

Frog peptides as anti-HIV microbicides

Peptides derived from the antimicrobial peptides secreted by frogs could function as microbicides to limit HIV transmission, while sparing protective vaginal bacteria.
By Leigh MacMillan
October 16, 2020

Clinical trial to test HIV drugs to treat COVID-19

Vanderbilt University Medical Center, in collaboration with the University of Colorado and Beth Israel Deaconess Medical Center in Boston, is leading one of the first “telemedicine” clinical trials to test a potential treatment for COVID-19.
By Bill Snyder
1 2 3 4 … 7